Skip to main content
Clinical Trials/ACTRN12612000055808
ACTRN12612000055808
Recruiting
Phase 4

Efficacy and safety of topical corticosteroid compared to placebo in the treatment of bacterial keratitis

niversity of Auckland0 sites144 target enrollmentJanuary 11, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Bacterial keratitis
Sponsor
niversity of Auckland
Enrollment
144
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 11, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Auckland

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of culture postivie bacterial keratitis, corneal defect less than or equal to 1\.5mm and not within 1\.0mm of the limbus, aged 16 or over, topical antibiotic given for at least three days with signs of clinical improvement.

Exclusion Criteria

  • Corneal perforation or impending perforation, descemetocele or endophthalmitis, evidence of herptic keratitis, fungal, or acanthambeoba infection by exam or history, pre\-existing corneal scar, use of topical steriod in affected eye or systemic corticosteriod during course of present infection, aged under 16 years, bilateral corneal infections, previous penetrating corneal transplant, pregnancy, best corrected vision worse than 6/60 in fellow eye, allergy to study drugs, uncontrolled systemic disease, concurrent ocular infections and patients requiring treatment with subconjuctival injection.

Outcomes

Primary Outcomes

Not specified

Similar Trials